Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001062993-15-003384)

Filing Details

Accession Number:: 0001062993-15-003384
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-15 15:39:40
Reporting Period:: 2015-06-15

Filing Date:: 2015-06-15
Accepted Time:: 2015-06-15 15:39:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1314052	Anavex Life Sciences Corp.	AVXL	Services-Commercial Physical & Biological Research (8731)	208365999

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1196573	U Christopher Missling	51 W 52Nd Street, 7Th Floor New York NY 10019-6163	President, Ceo, Cfo, Treasurer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-06-15	1,000	$0.43	3,004,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on June 3, 2015.
Includes 2,000,000 stock options that have vested and 1,000,000 shares of restricted common stock that have vested pursuant to the achievement of certain objectives. Does not include 3,000,000 shares of restricted common stock that vest pursuant to the achievement of certain objectives.